Contact
Please use this form to send email to PR contact of this press release:
Withdrawn application: Gazyvaro, obinutuzumab, Date of withdrawal: 04/07/2023, Post-authorisation
TO:
Please use this form to send email to PR contact of this press release:
Withdrawn application: Gazyvaro, obinutuzumab, Date of withdrawal: 04/07/2023, Post-authorisation
TO: